Skip to main content
. 2020 Feb 13;107(4):858–870. doi: 10.1002/cpt.1786

Figure 5.

Figure 5

Coverage of Cancer Immunity Cycle (CIC) by clinical omics datasets. The type of datasets obtained from high‐throughput experimental analysis of clinical samples, which can be integrated with observation of tumor growth in responding and nonresponding subjects to parameterize a full‐scale Quantitative Systems Pharmacology platform model of the CIC. MHC, major histocompatibility complex; TME, tumor microenvironment.